Structure-activity relationship of fluoroquinolone in Escherichia coli

Archives of Pharmacal Research

Volumn 21, Issue 2, 1998, Pages 106-112

  Lee, Soondeuk ^a   Park, Taeho ^b   Lee, Yeonhee ^a  

^a Seoul Women University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Escherichia coli; Fluoroquinolone; Structure Activity Relationship

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM; MICROBIOLOGICAL EXAMINATION; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; FLUOROQUINOLONES; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032035384     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974013     Document Type: Article

References (17)

1. Chu, D. T. W. and Fernandes, P. B., Structure-activity relationships of the fluoroquinolones. Antimicrob. Agents Chemother., 33, 131-135 (1989).
2. Coll, R., Gargallo-Viola, D., Tudela, E., Xicota, M. A., Llovera, S. and Guinea, J., Antibacterial activity pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob. Agents Chemother., 40, 274-277 (1996).
3. Gootz, T. D., McGuirk, P. R., Moynihan, M. S. and Haskell, S. L., Placement of alkyl substituents on the C-7 piperazine ring of fluroquinolones: Dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrob. Agents Chemother., 38, 130-133 (1994).
4. Heisig, P., Schedletzky, H. and Falkenstein-Paul, H., Mutations in the gyrA gene of a highly fluoroquinolone resistant clincal isolate of Escherichia coli. Antimicrob. Agents Chemother., 39, 696-701 (1993).
5. Hirai, K., Aoyama, H., Irikura, T., Iyobe, S. and Mitsuhashi, S., Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob. Agents Chemother., 29, 535-538 (1986).
6. Kim, K., Lee, S. and Lee, Y., Norfloxain resistance mechanism of E. coli 11 and E. coli 101-clinical isolates of Eschericha coli in Korea. Arch. Pharm. Res., 19, 353-358 (1996).
7. Kitamura, A., Hoshino, K., Kimura, Y., Hayakawa, I. and Sato, K., Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 39, 1467-1471 (1995).
8. Klopman, G., Fercu, D., Renau, T. E. and Jacobs, M. R., N-1-tert-Butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. Antimicrob. Agents Chemother., 40, 2637-2643 (1996).
9. Lee, Y., Kim, K., Pyun, H.-E. and Park, W., Characterization of ciprofloxacin, HK3140, norfloxacin, and ofloxacin resistant strains of Escherichia coli. Korean Biochem. J., 25, 134-140 (1992).
10. Mitscher, L. A., Devasthale, P. D. and Zavod, R., Structure-activity relationships, In Hooper, D. C., Wolfson, J. S. (Eds.). Quinolone antimicrobial agents, American Society for Microbiology, Washington D. C., pp. 3-52, 1993.
11. Mitscher, L. A., Zavoid, R. M. and Sharma, P. N., Structure-activity relationships of the newer quinolone antibacterial agents, In Fernandes P. B. (Eds.). Quinolones. J. R. Prous Science Publisher, Barcelona, pp 3-134, 1989.
12. Pan, X.-S., Ambler, J., Mehta, S. and Fisher, L. M., Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 40, 2321-2326 (1996).
13. Park, S., Lee, S. and Lee, Y., Norfloxacin resistance mechanism of Escherichia coli 59-a clinical isolate in Korea. Mol. Cells, 6, 469-472 (1996).
14. Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W. T., Cooper, C. S., Rosen, T. and Pernet, G., Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochem., 28, 3886-3894 (1989).
15. Tillotson, G. S., Quinolones: structure-activity relationships and future predictions. J. Med. Microbiol., 44, 320-324 (1996).
16. Wentland, M. P., Structure-activity relationships of fluoroquinolones, In Siporin, C., Heifetz, C. L., and Domagala, J. M. (Eds.). The new generation of quinolones. Marcel Decker, Inc., New York, pp. 1-44, 1990.
17. Wolfson, J. S. and Hooper, D. C., The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob. Agents Chemother., 28, 581-586 (1985).